Pinnacle Wealth Planning Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
16,962
+4,048
| +31% | +$36.3K | 0.02% | 433 |
|
|
2025
Q1 | $96.9K | Buy |
12,914
+204
| +2% | +$1.53K | 0.01% | 384 |
|
|
2024
Q4 | $95.6K | Sell |
12,710
-12,034
| -49% | -$90.5K | 0.01% | 373 |
|
|
2024
Q3 | $188K | Buy |
24,744
+1,708
| +7% | +$13K | 0.03% | 468 |
|
|
2024
Q2 | $142K | Buy |
+23,036
| New | +$142K | 0.02% | 449 |
|
|
2024
Q1 | – | Sell |
-20,561
| Closed | -$123K | – | 512 |
|
|
2023
Q4 | $123K | Buy |
+20,561
| New | +$123K | 0.02% | 440 |
|
|
2021
Q1 | – | Sell |
-143
| Closed | -$1K | – | 512 |
|
|
2020
Q4 | $1K | Buy |
+143
| New | +$1K | ﹤0.01% | 2057 |
|